Interleukin-17 Accelerates Allograft Rejection by Suppressing Regulatory T Cell Expansion
Author(s) -
Satoshi Itoh,
Naoyuki Kimura,
Robert C. Axtell,
Jeffrey B. Velotta,
Yongquan Gong,
Xi Wang,
Naoki Kajiwara,
Aya Nambu,
Eri Shimura,
Hideo Adachi,
Yoichiro Iwakura,
Hirohisa Saito,
Ko Okumura,
Katsuko Sudo,
Lawrence Steinman,
Robert C. Robbins,
Susumu Nakae,
Michael P. Fischbein
Publication year - 2011
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.110.014852
Subject(s) - immunology , medicine , transplantation , cd8 , il 2 receptor , t cell , cytokine , interleukin 21 , chemokine , pathogenesis , transplant rejection , inflammation , immune system
Interleukin-17 (IL-17), which is predominantly produced by T helper 17 cells distinct from T helper 1 or T helper 2 cells, participates in the pathogenesis of infectious, autoimmune, and allergic disorders. However, the precise role in allograft rejection remains uncertain. In the present study, we investigated the role of IL-17 in acute allograft rejection using IL-17-deficient mice.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom